Hepatocellular carcinoma (HCC) is a type of cancer that has high rates of recurrence and mortality. One of the most important factors that lead to treatment failure of HCC is the acquisition of multidrug resistance (MDR). Development of specific ligands for multidrug-resistant HCC will provide useful molecular tools for precise diagnosis and targeted theranostics. Herein, a multidrug-resistant HCC cell (HepG2/MDR)-specific aptamer was developed through Cell-SELEX (systematic evolution of ligands by exponential enrichment) technology. With dissociation constants lying in the nanomolar range, the molecularly designed PS-ZL-7c aptamer showed great selectivity to drug-resistant cancer cells. The imaging results illustrated that the PS-ZL-7c specifically accumulated in the drug-resistant tumors but not in drug-sensitive tumors and normal tissues, indicating that the PS-ZL-7c aptamer possessed excellent potential as a targeting ligand for precise diagnosis and target theranostics of multidrug-resistant HCC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acsami.1c12391 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A new class of penicillin-binding protein inhibitors to address drug-resistant .
bioRxiv
December 2024
Venatorx Pharmaceuticals, Inc., Malvern, PA, USA.
β-Lactams are the most widely used antibiotics for the treatment of bacterial infections because of their proven track record of safety and efficacy. However, susceptibility to β-lactam antibiotics is continually eroded by resistance mechanisms. Emerging multidrug-resistant (MDR) strains possessing altered alleles (encoding PBP2) pose a global health emergency as they threaten the utility of ceftriaxone, the last remaining outpatient antibiotic.
View Article and Find Full Text PDFInfections in cirrhosis.
Lancet Gastroenterol Hepatol
August 2024
Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, PA, USA. Electronic address:
Cirrhosis is an immune dysfunction state, and as such, patients with cirrhosis are susceptible to bacterial, fungal, and viral infections. Because of infection, these patients have a propensity to develop multiorgan failure, which is associated with high mortality. Bacterial infections are the most prevalent type of infection in patients with cirrhosis, with the prevalence of bacterial infections in patients admitted for an acute decompensating event ranging from 24% to 29%.
View Article and Find Full Text PDFExosomal circ_0032704 confers sorafenib resistance to hepatocellular carcinoma and contributes to cancer malignant progression by modulating the miR-514a-3p/PD-L1 pathway.
Ann Gastroenterol Surg
May 2024
Department of Pathology, the First Affiliated Hospital, Hengyang Medical School University of South China Hengyang Hunan China.
Article Synopsis
- The study investigates how circ_0032704 contributes to sorafenib resistance in hepatocellular carcinoma (HCC).
- The researchers utilized various assays to analyze the expression of circ_0032704, miR-514a-3p, and PD-L1, finding that circ_0032704 promotes resistance by regulating PD-L1 via miR-514a-3p.
- Inhibiting circ_0032704 reduced drug resistance and cancer cell proliferation, suggesting its potential as a biomarker in HCC diagnostics.
Green Synthesis of Molybdenum Nanoparticles From Solanum xanthocarpum and Evaluation of Their Antimicrobial and Antioxidant Activity Against Multidrug-Resistant Wound Isolates.
Cureus
March 2024
Department of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, IND.
Introduction: In recent years, antimicrobial drug resistance has emerged as a serious global public health concern, according to the World Health Organization data. The emergence of pathogens resistant to multiple drugs has been linked to an increase in morbidity and mortality from microbial infections. The study's main goal is to explore the efficacy of using in the green synthesis of molybdenum nanoparticles (Mo NPs) for antibacterial and antioxidant properties.
View Article and Find Full Text PDFTerlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis.
Aliment Pharmacol Ther
April 2024
Medical Clinic 1, University Hospital, Goethe-University Frankfurt, Frankfurt am Main, Germany.
Background: Patients with cirrhosis are susceptible to develop bacterial infections that trigger acute decompensation (AD) and acute-on-chronic liver failure (ACLF). Infections with multidrug-resistant organisms (MDRO) are associated with deleterious outcome. MDRO colonisation frequently proceeds MDRO infections and antibiotic therapy has been associated with MDRO colonisation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!